Wound care debridement codes (CPT 11042 through 11047 for surgical debridement, plus 97597 and 97598 for selective debridement) have been on the OIG’s continuing audit list for years, with audit findings consistently driven by depth-of-tissue documentation that does not support the code billed. The 2026 OIG Work Plan continues to flag debridement as a focused area, with reviews concentrating on outpatient wound care centers and home health programs. For practices delivering wound care across hospital outpatient departments, freestanding wound care centers, podiatry clinics, and primary care settings, the audit math is unforgiving: incorrect depth-of-tissue coding on a 30 percent error rate sample translates to extrapolated repayment across the full billing period, with interest.
The depth hierarchy that drives reimbursement
The surgical debridement codes are layered by depth of tissue removed during the encounter:
- 11042: debridement, subcutaneous tissue (first 20 sq cm or less).
- 11045: each additional 20 sq cm subcutaneous tissue (add-on to 11042).
- 11043: debridement, muscle and/or fascia (first 20 sq cm or less).
- 11046: each additional 20 sq cm muscle or fascia (add-on to 11043).
- 11044: debridement, bone (first 20 sq cm or less).
- 11047: each additional 20 sq cm bone (add-on to 11044).
The selective debridement alternative
CPT 97597 (selective debridement of open wound, first 20 sq cm or less) and 97598 (each additional 20 sq cm) are non-surgical debridement codes used for sharp debridement, low-frequency ultrasound debridement, or pulsatile lavage of open wounds. They reimburse at substantially lower rates than the 11042 series. The clinical and documentation distinction matters. Selective debridement removes nonviable tissue without crossing into subcutaneous tissue, while surgical debridement removes nonviable tissue down to or through subcutaneous tissue, muscle, fascia, or bone. The decision is documented by the depth of tissue removed, not the instrument used.
Documentation that supports the depth claimed
An audit-defensible debridement note documents the wound’s pre-debridement appearance and depth, the tissue type observed at each layer (epidermis, dermis, subcutaneous, muscle, fascia, bone), the depth of tissue removed during the procedure, the surface area treated in square centimeters, the instruments used, hemostasis achieved, and the post-debridement appearance. The most common audit failure is a note that describes the procedure in general terms without specifically naming the deepest tissue removed. A note that says “extensive debridement performed” supports nothing. A note that says “subcutaneous tissue debrided to bleeding edge across 12 sq cm wound bed, no muscle or fascia involvement” supports CPT 11042.
Surface area measurement
Surface area measurement is required documentation for every debridement code. The measurement should be performed pre-procedure (the wound’s actual size) and document the area debrided during the encounter. Measurements taken with a ruler against the wound, or with a wound-tracing tool, are acceptable. Estimates without documented measurement are not. The 20 sq cm threshold drives whether the practice bills the base code only or the base code plus the add-on (11045, 11046, or 11047). Practices that round upward to capture the add-on without documented measurement face automatic recoupment on audit.
Modifier 59 and bilateral procedures
When multiple wounds are debrided at the same visit, modifier 59 (distinct procedural service) applies to the second and subsequent codes for separate wounds. Each wound should be documented with its own location, dimensions, depth, and treatment. Bilateral wounds typically use the appropriate anatomic modifier (RT, LT) rather than 59. Wounds at different anatomic sites in the same encounter should have separate notes that establish the distinct procedural service. Practices that bill multiple debridement codes from a single combined wound note routinely face denials when the documentation does not support distinct services.
Frequency and medical necessity
Debridement is not a routine service. Each debridement encounter must establish medical necessity through documentation of nonviable tissue requiring removal, the patient’s risk profile (diabetes, peripheral vascular disease, immunocompromise), and the wound’s failure to progress under conservative management. LCDs typically expect debridement to occur on a clinically appropriate cadence, not on a fixed weekly schedule. Practices that bill debridement at every wound care visit, regardless of clinical findings, attract MAC TPE review and audit follow-up.
How MHB helps wound care practices
For wound care centers, podiatry practices, and primary care wound programs that want specialty-trained coders working their debridement claims with depth-of-tissue documentation review, surface area verification, and modifier discipline, our team supports specialty medical coding for wound care billing. The work runs in the practice’s existing EHR.
The bottom line
Debridement billing is mechanical when the documentation is structured. The depth, the surface area, the modifier discipline, and the medical necessity narrative are knowable at the time of the procedure. Practices that document them consistently survive audit. Practices that note “debridement performed” in the chart return the revenue and the interest when OIG arrives.
Authoritative sources
This article cites the following primary sources for billing-code and regulatory guidance. Always confirm current rules and codes with the publishing authority before applying to a specific claim.
